Wiskott-Aldrich syndrome: Another piece in the puzzle

Clinical and Experimental Immunology

Volumn 139, Issue 2, 2005, Pages 173-175

  Notarangelo, Luigi D ^a   Mori, L ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

B lymphocytes; Leucocyte trafficking; T lymphocytes; Wiskott Aldrich syndrome

Indexed keywords

WISKOTT ALDRICH SYNDROME PROTEIN;

ANTIGEN PRESENTING CELL; CELL COMPARTMENTALIZATION; DISEASE COURSE; ECZEMA; EDITORIAL; GENE IDENTIFICATION; GENE MUTATION; GENE THERAPY; HUMAN; IMMUNE DEFICIENCY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; THROMBOCYTOPENIA; WISKOTT ALDRICH SYNDROME;

B-LYMPHOCYTES; HUMANS; MUTATION; PROTEINS; T-LYMPHOCYTES; WISKOTT-ALDRICH SYNDROME; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 13544258624     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02707.x     Document Type: Editorial

References (33)

1. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 1994; 78:635-44 [erratum in: Cell 1999; 79: following 922].
2. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 1994; 78:635-44 [erratum in: Cell 1999; 79: following 922].
3. Villa A, Notarangelo L, Macchi P et al. X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet 1995; 9:414-17.
4. Notarangelo LD, Mazza C, Giliani S et al. Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia. Blood 2002; 99:2268-9.
5. Devriendt K, Kim AS, Mathijs G et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet 2001; 27:313-17.
6. Burns S, Cory GO, Vainchenker W, Thrasher AJ. Mechanisms of WASp-mediated haematological and immunological disease. Blood 2004; 12 August [Epub ahead of print].
7. Jin Y, Mazza C, Christie JR et al. Mutations of the Wiskott-Aldrich syndrome protein (WASP): hot spots, effect on transcription and translation and phenotype/genotype correlation. Blood 2004; 29 July [Epub ahead of print].
8. Filipovich AH, Stone JV, Tomany SC et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 2001; 97:1598-603.
9. Molina IJ, Kenney DM, Rosen FS, Remold-O'Donnell E. T cell lines characterize events in the pathogenesis of the Wiskott-Aldrich syndrome. J Exp Med 1992; 176:867-74.
10. Gallego MD, Santamaria M, Pena J, Molina IJ. Detective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation. Blood 1997; 90:3089-97.
11. Duprè L, Aiuti A, Trifari S et al. Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity 2002; 17:157-66.
12. Cooper MD, Chae HP, Lowman JT, Krivit W, Good RA. Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity. Am J Med 1968; 44:499-513.
13. Park JY, Kob M, Prodeus AP, Rosen FS, Shcherbina A, Remold-O'Donnell E. Early deficit of lymphocytes in Wiskott-Aldrich syndrome: possible role of WASP in human lymphocyte maturation. Clin Exp Immunol 2004; 136:104-10.
14. Orange JS, Ramesh N, Remold-O'Donnell E et al. Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc Natl Acad Sci USA 2002; 99:11351-6.
15. Gismondi A, Cifaldi L, Mazza C et al. Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT. Ability of IL-2 to correct NK cell functional defect. Blood 2004; 104:436-43.
16. Linder S, Nelson D, Weiss M, Apfelbacher M. Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages. Proc Natl Acad Sci USA 1999; 96:9648-53.
17. Badolato R, Sozzani S, Malacarne F et al. Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine. J Immunol 1998; 161:1026-33.
18. Zicha D, Allen WE, Brickell PM et al. Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome. Br J Haematol 1998; 101:659-65.
19. Binks M, Jones GE, Brickell PM, Kinnon C, Katz DR, Thrasher AJ. Intrinsic dendritic cell abnormalities in Wiskott-Aldrich syndrome. Eur J Immunol 1998; 28:3259-67.
20. Burns S, Thrasher AJ, Blundell MP, Machesky L, Jones GE. Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation. Blood 2001; 98:1142-9.
21. Burns S, Hardy SJ, Buddle J, Yong KL, Jones GE, Thrasher AJ. Maturation of DC is associated with changes in motile characteristics and adherence. Cell Motil Cytoskeleton 2004; 57:118-32.
22. de Noronha S, Hardy S, Sinclair J et al. Impaired dendritic cell homing in vivo in the absence of Wiskott-Aldrich syndrome protein. Blood 2004; 19 October [Epub ahead of print].
23. Ochs HD, Nelson DL, Stiehm ER. Other well-defined immunodeficiency syndromes: Wiskott-Aldrich syndrome (and X-linked thrombocytopenia). In: OchsHD, Stiehm ER, Winkelstein JA, eds. Immunologic disorders in infants and children, 5th edn. Philadelphia: Elsevier, 2004:506-16.
24. Facchetti F, Blanzuoli L, Vermi W et al. Detective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott-Aldrich syndrome. J Pathol 1998; 185:99-107.
25. Vermi W, Blanzuoli L, Kraus MD et al. The spleen in the Wiskott-Aldrich syndrome: histopathologic abnormalities of the white pulp correlate with the clinical phenotype of the disease. Am J Surg Pathol 1999; 23:182-91.
26. Westerberg L, Larsson M, Hardy SJ, Fernández C, Thrasher AJ, Severinson E. Wiskott-Aldrich syndrome protein deficiency leads to reduced B cell adhesion, migration, homing, and to a delayed humoral immune response. Blood 2004; 21 September [Epub ahead of print].
27. Park JY, Shcherbina A, Rosen FS, Remold-O'Donnell E. Phenotypic perturbation of B cells in the Wiskott-Aldrich syndrome. Clin Exp Immunol 2005; 139:297-305.
28. Holers VM, Boackle SA. Complement receptor 2 and autoimmunity. Curr Dis Autoimmun 2004; 7:33-48.
29. Prodeus AP, Goerg S, Shen LM et al. A critical role for complement in maintenance of self-tolerance. Immunity 1998; 9:721-31.
30. Shurman SH, Candotti F. Autoimmunity in Wiskott-Aldrich syndrome. Curr Opin Rheumatol 2003; 15:446-53.
31. Gulino AV, Moratto D, Sozzani S et al. Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome. Blood 2004; 104:444-52.
32. Allen CD, Ansel KM, Low C, Lesley R, Tamamura H, Fujii N, Cyster JG. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol 2004; 5:943-52.
33. Notarangelo LD, Ochs HD. Wiskott-Aldrich syndrome: a model for detective actin reorganization, cell trafficking and synapse formation. Curr Opin Immunol 2003; 15:585-91.